Please login to the form below
report
This page shows the latest report news and features for those working in and with pharma, biotech and healthcare.
Novartis makes case for gene therapy Zolgensma in SMA
It also called for Zolgensma to be priced somewhere between $900, 000 and $1.5m, however Novartis hit back at the report, saying that the cost-effective estimates are “designed around
Latest news
-
Chi-Med goes for third IPO in Hong Kong
New listing follows first product launch. Hutchison China MediTech, known as Chi-Med, has filed for an initial public offering in Hong Kong which according to some reports could to raise
-
EU files WTO dispute with Turkey over pharma laws
recent Reuters report.
-
Gilead and Galapagos close in on filing for Xeljanz rival
The safety of JAK inhibitors has once again come under the spotlight after regulators announced investigations into reports of life-threatening blood clots in patients taking a higher dose of
-
FDA approves Novartis' next-gen MS drug Mayzent
Mayzent will be priced slightly higher than Ocrevus at $88, 000 per year, but according to an ICER report the cost per additional QALY for the drug would exceed usual thresholds
-
Trump takes aim at Obamacare with repeal move
is against the advice of Health and Human Services Secretary Alex Azar and Attorney General Bill Barr, according to a Politico report.
More from news
Approximately 25 fully matching, plus 2,127 partially matching documents found.
Latest Intelligence
-
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
This was part of a drive towards greater transparency of pharma-sponsored clinical trials, in which a layperson summary formed part of an overall package, including the clinical study report, to
-
Galderma launches Rosacea awareness campaign
The Galderma-backed campaign builds on the 2018 report Rosacea: Beyond the Visible, which highlights the true extent of the psychosocial burden of rosacea globally.
-
#OrkambiNow?
This is despite reports from many patients of a transformative effect on their condition, and evidence that the drug can significantly cut pulmonary exacerbations, and the need for hospitalisation and intravenous
-
2019: CRISPR and therapeutic gene editing comes of age
All told, what is clear is that while He’s experiment has backfired spectacularly, with reports suggesting he is now under house arrest in China, it is up to companies like
-
China’s clinical trial shake-up
Going forward, all NDAs must include clinical trial self-inspection reports, giving the system a safeguard that could deter sponsors from running substandard studies and submitting flawed data.
More from intelligence
Approximately 0 fully matching, plus 235 partially matching documents found.
Latest appointments
-
New faces at GCI Health, Porterhouse Medical and Research Partnership
Walker, who will be based in London, will report to managing director Kath Kerry, who said: “Anyone who’s worked with Kim knows she’s passionate about what she does and
-
Changes at Oxford PharmaGenesis, Reynolds-Mackenzie and more
Bramham will report into Matt de Gruchy, who joined Reynolds-Mackenzie as chief executive officer at the beginning of 2018.
-
New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics
He will report directly to vice president of intercontinental regions, Kamal Abbasi.
-
Chameleon reveals new leadership line-up
He will report into Matt D’Auria, chief executive of Chameleon’s parent company Healthcare Consultancy Group.
-
Biogen appoints executive VP, corporate development
He will also become a member of the executive committee and will report directly to chief executive officer Michel Vounatsos, who said: “We are very pleased to welcome Daniel to Biogen
More from appointments
Approximately 0 fully matching, plus 148 partially matching documents found.
Latest from PMHub
-
Research Partnership launches new patient Living with Psoriasis 2017 (EU) report
The report will consist of 30-minute online interviews with 600 patients and 15 qualitative interviews. ... It can be purchased as either a 5EU report (sample of 500 patients) or as a 7EU report (sample of 600 patients with the additional countries of
-
Research Partnership has published a new patient Living with Atopic Dermatitis (US) report
Living with Atopic Dermatitis (AD) is a report based on a new study conducted amongst adult sufferers and parents of child sufferers. ... The report consists of 45-minute quantitative and 30-minute qualitative interviews with 152 AD sufferers in total.
-
Research Partnership launches new patient Living with Atopic Dermatitis (US) 2017 report
The report will consist of 45-minute quantitative and 30-minute qualitative interviews with AD patients and caregivers.
-
Modernising the Mental Health Act: Published Today
The final report of the Independent Review of the Mental Health Act 1983 has been published today, 6th December 2018. ... While there is still room for improvement this report gives a positive vision for future of approaches to mental health.”.
-
Report: Living With Rheumatoid Arthritis 2019 reports now available to purchase
We have published new Living with Rheumatoid Arthritis reports in 5EU, Japan and Canada. ... The reports consist of 30-minute quantitative online and qualitative telephone interviews with RA patients.
More from PMHub
Approximately 5 fully matching, plus 248 partially matching documents found.
Featured jobs
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Competitive salary and benefits
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Account Director, Medical Education
-
Salary TBC
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
-
Director – Healthcare PR
-
Salary TBC
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
-
Senior Medical Writer
-
Salary TBC
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Editor – Medical Education Agency – Bucks
-
Salary TBC
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
